nimustine has been researched along with Foot Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeya, T; Nitta, Y; Sakakibara, A; Tomita, Y | 1 |
| Abe, N; Irisawa, R; Kurashige, Y; Saito, M; Tsuboi, R | 1 |
2 other study(ies) available for nimustine and Foot Diseases
| Article | Year |
|---|---|
Therapy-related myelodysplastic syndrome developed by dacarbazine, nimustine hydrochloride and vincristine sulfate (DAV) therapy for patient with malignant melanoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Fatal Outcome; Female; Foot Diseases; Humans; Melanoma; Middle Aged; Myelodysplastic Syndromes; Nimustine; Retrospective Studies; Vincristine | 2011 |
Two cases of malignant melanoma of the toe developed skin ulcers following local injection of natural beta-interferon.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Foot Diseases; Humans; Interferon-beta; Melanoma; Nimustine; Skin Neoplasms; Skin Ulcer; Vincristine | 2012 |